DRAP Alerts On Toxic Cough Syrup With Propylene Glycol
Pakistani authorities have issued an urgent alert after discovering toxic compounds in raw materials used for cough syrup production. The toxic ingredients were reportedly found in a specific batch of raw materials imported from Thailand. The Drug Regulatory Authority of Pakistan (DRAP) directed the company to recall the cough syrup from other batches. The identified batch, labeled as C815N30R41, contains toxic substances in the imported raw material propylene glycol. The discovery raises concerns about the potential health risks associated with cough syrups, especially given recent cases of over 300 children’s deaths in Indonesia, Gambia, and Uzbekistan.
The World Health Organization (WHO) has previously linked deaths outside Indonesia to cough syrups made in India. The drug authority is investigating the entire supply chain of the contaminated solvent and has ordered the recall of products made from the same batch. Dow Chemical, the company in Thailand that supplied the raw materials, has not yet responded to inquiries.
The alert follows global concerns about the use of toxic propylene glycol in cough syrups, prompting health organizations to investigate its potential role in adverse health outcomes. The recall and investigation highlight the need for rigorous quality control and monitoring throughout the pharmaceutical supply chain to ensure the safety of medical products and protect public health.